Yu, Zhi
Kim, Seoyoung C.
Vanni, Kathleen
Huang, Jie
Desai, Rishi
Murphy, Shawn N.
Solomon, Daniel H.
Liao, Katherine P.
Funding for this research was provided by:
National Institutes of Health (R01 EB014947)
National Institutes of Health (U54 LM008748)
National Institutes of Health (U01 HG008685)
National Institutes of Health (U54 HG007963)
National Institutes of Health (R01 HL127118)
Patient-Centered Outcomes Research Institute (PCORI 282364.5077585.0007)
Harold and Duval Bowen Fund
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30 AR2072577)
Article History
Received: 2 December 2017
Accepted: 18 April 2018
First Online: 1 June 2018
Change Date: 8 July 2019
Change Type: Correction
Change Details: Following publication of the original article [1], it has come to our attention that we did not appropriately convert the units for CRP from the National Health and Nutrition Examination Survey (NHANES) from mg/dL to mg/L. In this study, NHANES was considered the general population cohort for this study; interestingly, the correction resulted in changes to a broader range of CRP values in NHANES from 0.01 to 18.0 mg/dL to 0.10 to 180.0 mg/L.
Ethics approval and consent to participate
: Our study protocol was approved by the Partners Healthcare Institutional Review Board.
: All authors have completed the Unified Competing Interest form and declare the following interests: SCK receives research grants to Brigham and Women’s Hospital from Pfizer, Lilly, Genentech, AstraZeneca, and Bristol-Myers Squibb. DHS receives research grants to Brigham and Women’s Hospital from Amgen, Lilly, Pfizer, AstraZeneca, Bristol-Myers Squibb, Genentech, and Corrona. He serves in an unpaid capacity on a Pfizer-sponsored trial on an unrelated topic. He receives royalties from UpToDate on unrelated topics. No other authors report any disclosures.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.